Xbrane Biopharma AB (XBRANE) — Capital Reinvestment Ratio
Xbrane Biopharma AB (XBRANE) has a Capital Reinvestment Ratio of 0.18x as of December 2024, meaning it reinvests 0% of its operating cash flow (Skr93.91 Million) in capital expenditures (Skr17.30 Million). Check XBRANE intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xbrane Biopharma AB Capital Reinvestment Ratio (2018–2018)
This chart tracks Xbrane Biopharma AB's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Xbrane Biopharma AB cash flow conversion.
Annual Capital Reinvestment Ratio for Xbrane Biopharma AB (2018–2018)
Year-by-year Capital Reinvestment Ratio for Xbrane Biopharma AB from 2018 to 2018. See Xbrane Biopharma AB (XBRANE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.03x | Skr46.71 Million | Skr1.60 Million | — |